Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0065 EUR | 0.00% | +8.33% | -35.00% |
2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
574K | - | - | - | - | - | |
115B | ||||||
106B | ||||||
24.69B | - | |||||
21.97B | - | |||||
19.27B |
- Stock Market
- Equities
- OVXA Stock
- Charts Ovoca Bio plc
- Sector Chart